News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
264,869 Results
Type
Article (13749)
Company Profile (101)
Press Release (251019)
Section
Business (88034)
Career Advice (465)
Deals (15342)
Drug Delivery (67)
Drug Development (36598)
Employer Resources (49)
FDA (6287)
Job Trends (6195)
News (150198)
Policy (14027)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (440)
Adcomms (6)
Allergies (30)
Alliances (23211)
ALS (35)
Alzheimer's disease (380)
Antibody-drug conjugate (ADC) (35)
Approvals (6316)
Artificial intelligence (98)
Autoimmune disease (7)
Automation (3)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (53)
Biotechnology (40)
Bladder cancer (17)
Brain cancer (15)
Breast cancer (74)
Cancer (558)
Cardiovascular disease (66)
Career advice (407)
Career pathing (11)
CAR-T (20)
Cell therapy (80)
Cervical cancer (4)
Clinical research (30837)
Collaboration (314)
Compensation (131)
Complete response letters (16)
COVID-19 (757)
CRISPR (19)
C-suite (109)
Cystic fibrosis (35)
Data (563)
Denatured (15)
Depression (9)
Diabetes (75)
Diagnostics (1312)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (53)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (32)
Earnings (31996)
Editorial (11)
Employer branding (4)
Employer resources (43)
Events (37338)
Executive appointments (345)
FDA (6657)
Featured Employer (20)
Friedreich's ataxia (2)
Funding (198)
Gene editing (37)
Generative AI (8)
Gene therapy (97)
GLP-1 (332)
Government (1285)
Grass and pollen (2)
Guidances (15)
Healthcare (3561)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (32)
Indications (12)
Infectious disease (788)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (41)
Interviews (59)
IPO (5874)
IRA (29)
Job creations (2050)
Job search strategy (373)
Kidney cancer (6)
Labor market (9)
Layoffs (176)
Leadership (3)
Legal (3429)
Liver cancer (19)
Lung cancer (75)
Lymphoma (50)
Machine learning (1)
Management (16)
Manufacturing (137)
MASH (29)
Medical device (1272)
Medtech (1274)
Mergers & acquisitions (9647)
Metabolic disorders (237)
Multiple sclerosis (17)
NASH (14)
Neurodegenerative disease (20)
Neuropsychiatric disorders (6)
Neuroscience (539)
NextGen: Class of 2025 (1585)
Non-profit (593)
Northern California (652)
Now hiring (7)
Obesity (136)
Opinion (118)
Ovarian cancer (20)
Pain (49)
Pancreatic cancer (13)
Parkinson's disease (41)
Partnered (5)
Patents (99)
Patient recruitment (28)
Peanut (9)
People (28834)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8028)
Phase II (13048)
Phase III (11705)
Pipeline (351)
Podcasts (45)
Policy (57)
Postmarket research (1401)
Preclinical (3199)
Press Release (25)
Prostate cancer (44)
Psychedelics (8)
Radiopharmaceuticals (119)
Rare diseases (156)
Real estate (2634)
Recruiting (17)
Regulatory (10056)
Reports (13)
Research institute (563)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (1)
RSV (6)
Schizophrenia (32)
Series A (35)
Series B (11)
Service/supplier (3)
Sickle cell disease (30)
Southern California (666)
Special edition (6)
Spinal muscular atrophy (76)
Sponsored (6)
Startups (1627)
State (2)
Stomach cancer (3)
Supply chain (28)
The Weekly (28)
United States (6640)
Vaccines (147)
Venture capitalists (13)
Webinars (10)
Weight loss (92)
Women's health (8)
Worklife (3)
Date
Today (34)
Last 7 days (192)
Last 30 days (992)
Last 365 days (12129)
2025 (2716)
2024 (12500)
2023 (14247)
2022 (19558)
2021 (20068)
2020 (19034)
2019 (14886)
2018 (11713)
2017 (13892)
2016 (13132)
2015 (15473)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (51)
Arkansas (3)
Asia (20060)
Australia (2602)
California (1583)
Canada (854)
China (213)
Colorado (64)
Connecticut (65)
Delaware (51)
Europe (39302)
Florida (294)
Georgia (34)
Idaho (9)
Illinois (179)
India (13)
Indiana (125)
Iowa (1)
Japan (80)
Kansas (54)
Kentucky (12)
Maine (2)
Maryland (242)
Massachusetts (1362)
Michigan (27)
Minnesota (88)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (7)
New Hampshire (6)
New Jersey (690)
New Mexico (7)
New York (461)
North Carolina (370)
North Dakota (2)
Northern California (652)
Ohio (48)
Oklahoma (4)
Oregon (16)
Pennsylvania (399)
Puerto Rico (8)
Rhode Island (6)
South America (501)
South Carolina (2)
Southern California (666)
Tennessee (34)
Texas (211)
Utah (33)
Virginia (68)
Washington D.C. (29)
Washington State (109)
Wisconsin (14)
264,869 Results for "amneal pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA
March 3, 2025
·
6 min read
Press Releases
Amneal to Participate at Upcoming March 2025 Investor Conference
March 11, 2025
·
1 min read
GLP-1
Obesity Startup Metsera Inks Manufacturing Pact With Amneal on Heels of Phase I Readout
A week after it released positive early-stage data, Metsera has partnered with Amneal Pharmaceuticals in an effort to secure the development and supply of its investigational weight loss therapy MET-097.
October 1, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Amneal Reports Fourth Quarter and Full Year 2024 Financial Results
February 28, 2025
·
20 min read
Pharm Country
Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the addition of omalizumab, referencing XOLAIR ® , to its biosimilar pipeline.
July 1, 2024
·
7 min read
Press Releases
Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide
February 19, 2025
·
4 min read
Pharm Country
Amneal Releases 2023 Environmental, Social and Governance Report
Amneal Pharmaceuticals, Inc. announced the release of its fourth Environmental, Social and Governance Report.
June 28, 2024
·
9 min read
Parkinson’s disease
Amneal Wins FDA Approval for Extended-Release Oral Parkinson’s Drug
Crexont was previously rejected by the regulator in June 2023, citing insufficient safety data. However, Amneal Pharmaceuticals’ resubmission included findings from a healthy volunteer study.
August 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Amneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025
January 29, 2025
·
1 min read
Press Releases
Amneal to Participate at Upcoming Investor Conferences
December 4, 2024
·
2 min read
1 of 26,487
Next
